![]() | ![]() |
Formats:
|
||||||||||
Maternal presence serves as a switch between learning fear and attraction in infancy Department of Zoology, University of Oklahoma, Norman, Oklahoma 73019, USA. Correspondence should be addressed to R.M.S. (Email: rsullivan/at/ou.edu). The publisher's final edited version of this article is available at Nat Neurosci. See other articles in PMC that cite the published article.Abstract Odor-shock conditioning produces either olfactory preference or aversion in preweanling (12–15 days old) rats, depending on the context. In the mother’s absence, odor-shock conditioning produces amygdala activation and learned odor avoidance. With maternal presence, this same conditioning yields an odor preference without amygdala activation. Maternal presence acts through modulation of pup corticosterone and corticosterone’s regulation of amygdala activity. Over-riding maternal suppression of corticosterone through intra-amygdala corticosterone infusions permits fear conditioning and amygdala activation. Here we show two circuits for odor-shock conditioning, with maternal presence providing the ‘switch’ by lowering pups’ corticosterone levels. Because pups must learn the diet-dependent maternal odor for interactions with the mother (such as nipple attachment and approach), this system ensures that pups only learn to approach maternal odor. The mother’s ability to modify fear learning circuitry may provide clues to abusive attachment and predisposition for mental illness and altered emotional expression later in life1–3. The validity of an animal model of abusive attachment is strengthened by the wide phylogenetic representation of abusive attachment, which has been documented in chicks, infant dogs, rodents and nonhuman primates4,5. Moreover, these data provide insight into the timing and mechanisms of functional emergence of brain areas during development. During early life when pups are confined to the nest (the ‘sensitive period’), they exhibit potentiated preference learning and attenuated aversion learning, characterized by odor preferences induced by conditioning with an odor and a 0.5-mA shock6–8. This paradoxical learning does not reflect the pups’ inability to feel pain or threshold differences9, but reflects the inability of odor-shock conditioning to engage the amygdala8,10–12. The sensitive period ends as the pups’ ability to walk emerges and life outside the nest begins (at age 10 d), with a rapid transition to independence by age 21–23 d. In this ‘postsensitive period’, preweanling rats are in a transitional period from dependence to independence. At this stage, the pups need both continued interactions with the mother as well as the engagement of contingency-dependent learning for survival outside the nest. The effects of maternal presence on odor-pain conditioning may ensure that pups continue to only learn approach responses to her odors, whereas in her absence they learn complex contingencies required for survival outside the nest. Here we present data illustrating that odor-shock learning (0.5-mA shock) in pups accommodates their changing developmental needs. Odor-shock conditioning resulted in an odor preference at an age when pups were confined to the nest (Fig. 1a
Our rationale for assessing how the mother could function as a ‘switch’ between the two learning systems was based on previous data. First, the termination of the sensitive period is coincident with the gradual decline of the pups’ ‘stress hyporesponsive period’ when stressors such as shock begin to produce a surge in corticosterone release11,13. In preweanling pups, odor-shock conditioning requires that corticosterone produce odor aversion learning and basolateral amygdala plasticity11,12. Indeed, giving corticosterone to 7-d-old (that is, sensitive period) pups permits aversion learning and engages the amygdala, whereas depleting 12-d-old (that is, postsensitive period) pups of corticosterone (by adrenalectomy) reinstates the sensitive period11,12. Second, maternal presence suppresses shock-induced corticosterone release in preweanling pups14. Here we used 12- to 15-d-old (postsensitive period) pups in an odor-shock fear conditioning protocol (0.5-mA shock) similar to one that engages the amygdala in adult rats15. For the paired presentations, pups were administered 11 0.5-mA, 1-s-long tail shocks during the last second of a 30-s-long presentation of a peppermint odor. Controls received either the odor only or unpaired presentations of odor and shock (details in Supplementary Methods online). Pups were conditioned in either the presence or the absence of an anesthetized mother and were tested the next day in a Y-maze (conditioned odor versus the familiar odor of clean bedding). Pups subjected to odor-shock without maternal presence learned to avoid the odor. In contrast, pups subjected to odor-shock with maternal presence developed the paradoxical shock-induced odor preference (Fig. 1b
Due to the important role of corticosterone in infant rat learning and in the mother’s ability to reduce shock-induced corticosterone release in pups, we assessed corticosterone’s effect on learning and amygdala activity10,11. Corticosterone levels during conditioning were significantly higher in pups subjected to paired conditioning without maternal presence than in those with maternal presence, including shock and nonshock groups (Fig. 3a
In summary, our data suggest that preweanling pups have two odor-shock learning circuits, with maternal presence providing suppression of stress-induced corticosterone release and engaging the odor-shock circuit for odor preference learning supporting infant-mother attachment. These data provide insight into the timing and mechanisms of functional emergence of the amygdala and suggests ways in which the functional maturation of brain development may be disrupted by stress. Supplementary Methods Click here to view.(129K, pdf) Supplementary Figure 1 Click here to view.(796K, pdf) Supplementary Figure 2 Click here to view.(1.0M, pdf) Supplementary Figure 3 Click here to view.(11M, pdf) Supplementary Figure 4 Click here to view.(3.6M, pdf) Acknowledgments Supported by grants to R.M.S. from the US National Institute of Child Health and Human Development (HD33402), the US National Science Foundation (IOB0544406) and the Oklahoma Center for the Advancement of Science and Technology; and by funds to S.M. from the University of Oklahoma. Footnotes Note: Supplementary information is available on the Nature Neuroscience website. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Reprints and permissions information is available online at http://npg.nature.com/reprintsandpermissions/ References 1. Teicher MH, et al. Neurosci Biobehav Rev. 2003;27:33–44. [PubMed] 2. Heim C, Nemeroff CB. Biol Psychiatry. 2001;49:1023–1039. [PubMed] 3. Pollak SD, Kistler DJ. Proc Natl Acad Scl USA. 2002;99:9072–9076. 4. Sullivan PM. Ann NY Acad Sci. 2003;1008:122–131. [PubMed] 5. Maestripieri D, Lindell SG, Ayala A, Gold PW, Higley JD. Neurosci Biobehav Rev. 2005;29:51–57. [PubMed] 6. Haroutunian V, Campbell BA. Science. 1979;205:927–929. [PubMed] 7. Camp LL, Rudy JW. Dev Psychobiol. 1988;21:25–42. [PubMed] 8. Sullivan PM, et al. Nature. 2000;407:38–39. [PubMed] 9. Barr GA. NIDA Res Monogr. 1995;158:172–201. [PubMed] 10. Roth TL, Sullivan PM. Biol Psychiatry. 2005;57:823–831. [PubMed] 11. Levine S. Eur J Pharmacol. 2000;405:149–160. [PubMed] 12. Moriceau S, Wilson DA, Levine S, Sullivan RM. J Neurosci. 26:6737–6748. [PubMed] 13. Moriceau S, Sullivan RM. Behav Neurosci. 2004;118:274–281. [PubMed] 14. Stanton ME, Levine S. Dev Psychobiol. 1990;23:411–426. [PubMed] 15. Fanselow MS, LeDoux JE. Neuron. 1999;23:229–232. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||
Neurosci Biobehav Rev. 2003 Jan-Mar; 27(1-2):33-44.
[Neurosci Biobehav Rev. 2003]Ann N Y Acad Sci. 2003 Dec; 1008():122-31.
[Ann N Y Acad Sci. 2003]Neurosci Biobehav Rev. 2005 Feb; 29(1):51-7.
[Neurosci Biobehav Rev. 2005]Science. 1979 Aug 31; 205(4409):927-9.
[Science. 1979]Nature. 2000 Sep 7; 407(6800):38-9.
[Nature. 2000]NIDA Res Monogr. 1995; 158():172-201.
[NIDA Res Monogr. 1995]Biol Psychiatry. 2005 Apr 15; 57(8):823-31.
[Biol Psychiatry. 2005]J Neurosci. 2006 Jun 21; 26(25):6737-48.
[J Neurosci. 2006]Eur J Pharmacol. 2000 Sep 29; 405(1-3):149-60.
[Eur J Pharmacol. 2000]Behav Neurosci. 2004 Apr; 118(2):274-81.
[Behav Neurosci. 2004]J Neurosci. 2006 Jun 21; 26(25):6737-48.
[J Neurosci. 2006]Dev Psychobiol. 1990 Jul; 23(5):411-26.
[Dev Psychobiol. 1990]Neuron. 1999 Jun; 23(2):229-32.
[Neuron. 1999]Ann N Y Acad Sci. 2003 Dec; 1008():122-31.
[Ann N Y Acad Sci. 2003]Behav Neurosci. 2004 Apr; 118(2):274-81.
[Behav Neurosci. 2004]Biol Psychiatry. 2005 Apr 15; 57(8):823-31.
[Biol Psychiatry. 2005]Eur J Pharmacol. 2000 Sep 29; 405(1-3):149-60.
[Eur J Pharmacol. 2000]J Neurosci. 2006 Jun 21; 26(25):6737-48.
[J Neurosci. 2006]Behav Neurosci. 2004 Apr; 118(2):274-81.
[Behav Neurosci. 2004]